What is Tyra Biosciences, Inc.'s net change in cash?

Tyra Biosciences, Inc. (TYRA) reported net change in cash of $7.57M in Q1 2026.

How has Tyra Biosciences, Inc.'s net change in cash changed year-over-year?

Tyra Biosciences, Inc.'s net change in cash decreased by 13.6% year-over-year, from $8.76M to $7.57M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Tyra Biosciences, Inc. TYRA Net Change in Cash

Net Change in Cash at other companies

IncyteINCY

$363.28M+43.1%

BioMarin PharmaceuticalsBMRN

$1.76B+1,562%

UroGen PharmaURGN

-$800K+98.8%

BridgeBio PharmaBBIO

$309.88M+321%

ArriVent BioPharma, Inc.AVBP

$16.56M+168%

Syndax PharmaceuticalsSNDX

-$4.04M-4,386%

Other financials

Income statement

See full

Operating income-$42.0M-31.9%

Net income-$39.3M-39.6%

EPS (diluted)-$0.64-36.2%

Balance sheet

See full

Cash & equivalents$85.0M-15.7%

Total debt$5.7M-6.9%

Total equity$387.6M+19.8%

Total assets$412.0M+20.0%

Cash flow

See full

Operating cash flow-$32.6M-27.9%

CapEx$88.0K+529%

Free cash flow-$32.7M-28.2%

Valuation

See full

Market cap$1.81B+318%

Enterprise value$1.73B+397%

Returns & leverage

See full

Return on equity-36.9%+21.1pp

Debt / equity0×0.0×

Current ratio20.5×-2.3×

Where this comes from

Reported directly by Tyra Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tyra Biosciences, Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tyra Biosciences, Inc.'s net change in cash?: Tyra Biosciences, Inc. (TYRA) reported net change in cash of $7.57M in Q1 2026.
How has Tyra Biosciences, Inc.'s net change in cash changed year-over-year?: Tyra Biosciences, Inc.'s net change in cash decreased by 13.6% year-over-year, from $8.76M to $7.57M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.